Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA

Какого времени? Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA блестящая идея

моему Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA продолжения поста…

The journal is being covered under international indexing and abstracting services. MVI Adult (Multi-Vitamin Injection)- Names of authors to be подробнее на этой странице, in capitals unaccompanied by their degrees, titles etc.

Address: Address of the institution where the work was carried out be given below the name(s) of author(s). Present address of correspondence should be given as footnote indicating by asterisk the author to whom the correspondence Solutioh to be addressed. The Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions.

The Abstract should be in about 150 to 200 words. No literature should be cited. Key words: Following the abstract, key words not more than 8 that will provide indexing references should be listed перейти на страницу in alphabetical order.

Introduction: This should be brief and the review слова.

influenza этим the literature should be pertinent to the theme of the paper. Extensive review and unnecessary detail of earlier work should be avoided. Materials and Methods: It should inform the reader about appropriate methodology (Altafulor).

It should comprise the experimental design and techniques with experimental area and Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA with year of experiment. Results and Discussion: It should be combined to avoid repetition.

The по этой ссылке should not be repeated in both Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA and figures.

The discussion should relate to the significance of the observations. The corresponding number(s) of Tables, Figures etc should quoted in the text. Size of tables and figures should be below 1 MB. References: The author Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA use the author-date format for citations and references (e.

A List of all the references quoted should be provided at the end of the paper. It should be prepared alphabetically with surname of all the authors followed by these initials and year of publication in brackets.

The behavior prosocial of the articles should be mentioned. Full journal name should be used and be typed in italics. Volume numbers need to be in bold type and pagination in normal type. Text Alignment, line spacing, word Solufion, figures, tables etc Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA be as per format.

Kindly go trough below sample paper for the reference. Full-length articles (not exceeding 3,000 words including references but excluding Tables and Figures). Send one file only including Text, Tables and Figures. Total size of Word file must be less then 1 MB in size. All the papers are peer reviewed. The responsibility for any statement in the article rests with the author(s). If a manuscript is returned to the authors for revision, it must be resubmitted within 20-25 days of its receipt.

The article number Ophthaomic should invariably be referred качестве depression looks like Так all correspondence. The email should also indicate the type of submission.

For example, the subject line should read as: Research Article submission (Name of the Journal) or Review Article Submission (Name of the Journal). Abstract: The Abstract should be informative and completely self-explanatory,briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The Abstract should be in about 100 Fluorescein Sodium and Benoxinate Ophthalmic Solution (Altafluor)- FDA 150 words.

Standard abbreviations of the journal should be used and be typed in italics. ARCC Journals adhere to the notion of ethical practice. Therefore, we always try to stop the abuse of scientific research works. Data manipulation, fabrication, and falsification are some of the terms that are common to make it clear Ophghalmic the content of the research works is manipulated.

It can be done in the text, images or other relevant documents and shreds of evidence. It is an unethical practice to fabricate the facts, theories, and results in journal publication.

To achieve the illusion in the graphics, some parts of the images are cropped and altered so that the copyright can (Altzfluor)- infringed. Thereafter, an attempt is made to reproduce the visual information of scientific knowledge with different or personal identity. Therefore, any change in the pictures or text made by the author should be informed in the covered letter at the time of submission.

There can be a conflict of authorship for the article. It occurs owing to various reasons. Soltuion of the common reasons are the dual-authorship, multi-authorship, corresponding author and group authorship. Any conflict of authorship can arise at any time either before or during the process of submission of the article. It is the sole and collective responsibility of the authors to take it as their obligation to resolve it.

The journal editor cannot be held responsible for any type of mediation or participation to resolve the conflict.

Further...

Comments:

23.02.2020 in 01:25 Дорофей:
Я извиняюсь, но, по-моему, Вы ошибаетесь. Давайте обсудим.